Adverse drug reactions among patients initiating second-line antiretroviral therapy in South Africa

By  Dr Dorina Onoya  Kamban Hirasen  Liudmyla van den Berg  Jacqui Miot  Lawrence Long  Matthew Fox  |  | 

Understanding the occurrence of ARV-related adverse events among patients receiving second-line ART is important in preventing switches to more limited and expensive third-line regimens.

Publication details

Drug Safety
#10
2018
1007
PDF